News

Pharmabiz12h
Marengo begins patient dosing in STARt-002 phase 1b/2 study of invikafusp alfa in combo with TROP2-directed ADC Trodelvy in metastatic breast cancer
Cambridge, Massachusetts Saturday, May 10, 2025, 18:00 Hrs [IST] ...
Ophthalmology Times14h
Belantamab mafodotin–induced corneal changes in patients with multiple myeloma
Researchers uncover corneal changes in multiple myeloma patients treated with belantamab mafodotin, revealing potential ...
Engineered T-cells that express both CARs and TCRs can better distinguish between cancerous and healthy tissues
Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...